92 related articles for article (PubMed ID: 12371629)
1. The effects of nitric oxide donors and inhibitors on neutrophil functions in Behçet's disease.
Atalay G; Eksioglu-Demiralp E; Akoglu T; Direskeneli H
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S17-20. PubMed ID: 12371629
[TBL] [Abstract][Full Text] [Related]
2. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil activation in Behçet's disease.
Eksioglu-Demiralp E; Direskeneli H; Kibaroglu A; Yavuz S; Ergun T; Akoglu T
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S19-24. PubMed ID: 11760393
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic proline-rich polypeptide is a regulator of oxidative burst in human neutrophils and monocytes.
Davtyan TK; Manukyan HA; Mkrtchyan NR; Avetisyan SA; Galoyan AA
Neuroimmunomodulation; 2005; 12(5):270-84. PubMed ID: 16166806
[TBL] [Abstract][Full Text] [Related]
5. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism.
Welters ID; Menzebach A; Goumon Y; Langefeld TW; Teschemacher H; Hempelmann G; Stefano GB
J Neuroimmunol; 2000 Nov; 111(1-2):139-45. PubMed ID: 11063831
[TBL] [Abstract][Full Text] [Related]
6. Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome.
Gogus F; Fresko I; Elbir Y; Eksioglu-Demiralp E; Direskeneli H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S81-5. PubMed ID: 16273771
[TBL] [Abstract][Full Text] [Related]
7. S-nitrosoglutathione enhances neutrophil DNA fragmentation and cell death.
Fortenberry JD; Owens ML; Brown LA
Am J Physiol; 1999 Mar; 276(3):L435-42. PubMed ID: 10070107
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.
Perazzio SF; Soeiro-Pereira PV; Dos Santos VC; de Brito MV; Salu B; Oliva MLV; Stevens AM; de Souza AWS; Ochs HD; Torgerson TR; Condino-Neto A; Andrade LEC
Arthritis Res Ther; 2017 Oct; 19(1):235. PubMed ID: 29052524
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone, colchicine and iodine-lithium-alpha-dextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Behçet's disease.
Davtyan TK; Mkrtchyan NR; Manukyan HM; Avetisyan SA
Int Immunopharmacol; 2006 Mar; 6(3):396-407. PubMed ID: 16428075
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
[TBL] [Abstract][Full Text] [Related]
11. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
Schindler C; Leuschner S; Schwanebeck U; Kirch W
J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
[TBL] [Abstract][Full Text] [Related]
12. Activation of neutrophils by testosterone in Behçet's disease.
Yavuz S; Ozilhan G; Elbir Y; Tolunay A; Eksioglu-Demiralp E; Direskeneli H
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S46-51. PubMed ID: 17949551
[TBL] [Abstract][Full Text] [Related]
13. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
[TBL] [Abstract][Full Text] [Related]
14. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
16. Interaction of endothelin-1 and nitric oxide in endothelial barrier failure in the cat hindlimb.
Porter LP; McNamee JE; Wolf MB
Microcirculation; 2000 Oct; 7(5):347-56. PubMed ID: 11079252
[TBL] [Abstract][Full Text] [Related]
17. The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production.
Tavares-Murta BM; Cunha FQ; Ferreira SH
Br J Pharmacol; 1998 Aug; 124(7):1369-74. PubMed ID: 9723947
[TBL] [Abstract][Full Text] [Related]
18. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of neutrophil functions after experimental abdominal surgical trauma.
Shijo H; Iwabuchi K; Hosoda S; Watanabe H; Nagaoka I; Sakakibara N
Inflamm Res; 1998 Feb; 47(2):67-74. PubMed ID: 9535544
[TBL] [Abstract][Full Text] [Related]
20. Impaired endotoxin tolerance induction in patients with familial Mediterranean fever.
Davtyan TK; Hakopyan GS; Avetisyan SA; Mkrtchyan NR
Pathobiology; 2006; 73(1):26-39. PubMed ID: 16785765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
